Company Active LTD

Company profile

Aseptika Limited

Activ8rlives | App Connected Health Products

A high quality range of App connected health products designed to improve your daily wellbeing and long-term health. Discover our range of general health and asthma monitors.

CRN
06425174
Founded
2007
Age
18

Overview

Legal name
ASEPTIKA LIMITED
Region
East of England
Registered address
Unknown
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

4 events
13 Sep
2024

Change Registered Office Address Company With Date Old Address New Address

Address

AD01 | Transaction MzQzNDk0MzI2MWFkaXF6a2N4 | Paper/PDF filed

Published 14 Sep 2024 07:00

22 Aug
2024

Liquidation Voluntary Appointment Of Liquidator

Insolvency

600 | Transaction MzQzMjYzNTQ5MWFkaXF6a2N4 | Paper/PDF filed

Published 23 Aug 2024 12:01

22 Aug
2024

Liquidation Voluntary Statement Of Affairs

Insolvency

LIQ02 | Transaction MzQzMjYzNTIzNmFkaXF6a2N4 | Paper/PDF filed

Published 23 Aug 2024 12:01

13 Nov
2007

Incorporated

Inception

Company registered at Companies House

Public funding

12 awards
First funded
2013
Funded years
2013, 2014, 2015, 2017, 2018, 2019, 2020, 2021, 2022, 2023
Age at first award
5 years

Projects

2023 Collaborative R&D Lead participant

Title: Moving medically certifiable AI algorithms from the Cloud and onto the Medi-OS Operating System of Medical Devices to automate, make robust and increase uptake of AI in healthcare: Use-case will be community-based spirometry.

1 May 2023 to 31 Jul 2023

Awarded
£47,630
Total cost £47,630

Spirometry is a simple medical test used to help diagnose and monitor lung conditions by measuring how much air a patient can breathe out in one forced breath. The medical monitor is called a spirometer. Spirometry is performed by a trained nurse or physiologist in a GP surgery or during a visit to a hospital clinic. There is a Worldwide shortage of train...

2023 Collaborative R&D Lead participant

A universal 5G connected Smart Inhaler Tracker and motivator for ALL inhaler types and patients of all ages with respiratory disease to increase adherence and reduce hospitalisations.

1 Jan 2023 to 31 Dec 2023

Awarded
£349,900
Total cost £499,857

Respiratory diseases are the world's leading causes of death and disability. 200 million people (4% of the world's population) have Chronic Obstructive Pulmonary Disease and 3.2 million die of it each year. Asthma affects 350 million people worldwide and is the most common chronic disease of childhood. A review of 40 different studies with 15,000 people, ...

2022 Collaborative R&D Lead participant

Industrial Research to generate evidence for submission to NICE using a novel, real-world trial design for a technology-enabled, blended service for Cardiac Rehabilitation.

1 Oct 2022 to 31 Mar 2024

Awarded
£245,566
Total cost £350,809

**WHAT IS THE PROBLEM?** Whilst cardiac rehabilitation reduces the risk of death and future heart attacks and improves the quality of life for patients, only about half of those invited attended the group-based programmes that were provided prior to the COVID-19 pandemic. During the pandemic, many cardiac rehabilitation services were moved online or to re...

2021 Innovation Loans Lead participant

Into production and commercialisation: Medi-OS medically certified operating system

19 Jan 2021 to 19 Jan 2023

Awarded
£100,000
Total cost £1,565,685

The pandemic has challenged healthcare providers around the world as they deliver care for patients with non-COVID-19 cardiovascular and respiratory conditions. By necessity, remote consultations have rapidly replaced many in-person clinics and assessments. In parallel, patients have also quickly adopted the convenience of medical monitoring in the home a...

2020 Feasibility Studies Lead participant

Deployment of Active+me for remote patient support and cardiac rehabilitation for vulnerable patients in isolation, following heart surgery.

1 Jun 2020 to 31 Mar 2021

Awarded
£74,993
Total cost £74,993

Prior to the Covid-19 pandemic, recovery after heart surgery was optimised by engaging the patient in a rehabilitation process, arranged in stages: * Phase I at the bedside after the procedure. * Phase II as an out-patient * Phase III as a series of exercise workouts and lifestyle education classes over 6-8 weeks (conducted by nurses and/or physiotherapis...

2019 Collaborative R&D Lead participant

Asthma+me SMART: Development of an AI-supported clinical decision support system for children with moderate-to-severe asthma treated in specialist paediatric clinics.

1 Mar 2019 to 28 Feb 2021

Awarded
£243,903
Total cost £348,433

"Asthma affects 1.1 million UK children costing more than £58m per annum. Aseptika's cloud-based technology supporting disease management (www.activ8rlives.com) is ready to be developed as a clinical healthcare management device. Our previous SBRI/Innovate UK projects shows that paediatric asthma patients, once referred to the specialist clinic, tend to r...

2019 CR&D Bilateral Lead participant

Asthma +me (CE-marked, Class 1 Medical Device): RCT for digital alternative care pathway to unblock paediatric asthma outpatient clinics.

1 Jan 2019 to 31 Mar 2020

Awarded
£116,250
Total cost £232,500

Asthma is the most common chronic medical condition among children and young people in the UK and an NHS priority (NHS England). 932,000 children in England receive treatment for asthma. It is the most frequent reason for emergency admission and the UK has the third highest risk of death from childhood asthma in OECD nations (Asthma UK). The current care ...

2018 Feasibility Studies Lead participant

Automating prediction of exacerbation in respiratory disease using complex data-sets generated at home by patients. An unmet clinical need.

1 Mar 2018 to 28 Feb 2019

Awarded
£47,491
Total cost £67,844

"Incurable respiratory diseases are characterised by frequent exacerbations (flare-ups), worsened health status, rapid lung function decline caused by infections (bacterial or viral), triggered by air pollution, cold temperatures or other environmental factors. Airway inflammation and increased mucus production result in deteriorating airflow, dynamic hyp...

2017 Collaborative R&D Lead participant

BuddyWOTCH, a wearable Class IIa medical device for stratification of long-term conditions

1 Oct 2017 to 30 Sep 2019

Awarded
£439,298
Total cost £627,569

17.5 million people in UK have long-term conditions, that through enhanced monitoring, could be better stratified to the correct treatment pathway, with resulting savings to the NHS and better patient outcomes. This project finalises development of a wristband medical device that enables constant monitoring and detection of exacerbation warning signs in p...

2015 Feasibility Studies Lead participant

Automation of sputum biomarker analysis for respiratory disease in Self-Management (Diagnostics).

1 Jun 2015 to 31 Aug 2015

Awarded
£23,100
Total cost £33,000

Respiratory disease is the EU's 2nd largest cause of premature death, resulting from years of a slow decline in health. Hospitalisation for 14 day periods become frequent as prognosis worsens - highly disruptive for patient and family carers. Self-management through self-monitoring at home, through patient/carer training and empowerment reduces frequency ...

2014 Vouchers Lead participant

Cyber security - Always Connected

1 May 2014 to 31 Oct 2014

Awarded
£5,000
Total cost £5,000

Providing sophisticated security of information and data transfer to support the use of self-management solutions for those with long-term health conditions in their own homes.

2013 Collaborative R&D Lead participant

Always connected and user-free set-up for self monitoring y patients at home.

1 Jun 2013 to 31 May 2014

Awarded
£46,200
Total cost £77,000

Two SMEs will develop a complex system breadboard which will form the basis of several future devices for applications in automomous consumer health and medical monitoring. These require wireless device-cloud and device-device data transfer to simplify processes for the user and to enable a reduction in healthcare-related costs. The limitations of current...

Product types

Collaborative R&D CR&D Bilateral Feasibility Studies Innovation Loans Vouchers